PharmaTher Holdings Ltd.
PHRM
CNSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 589.40K | 625.40K | 675.70K | 620.90K | 643.50K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 997.10K | 1.09M | 1.09M | 999.20K | 1.06M |
| Operating Income | -997.10K | -1.09M | -1.09M | -999.20K | -1.06M |
| Income Before Tax | -1.05M | -1.14M | -1.09M | -1.07M | -1.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.05 | -1.14 | -1.09 | -1.07 | -1.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.05M | -1.14M | -1.09M | -1.07M | -1.08M |
| EBIT | -997.10K | -1.09M | -1.09M | -999.20K | -1.06M |
| EBITDA | -619.20K | -855.30K | -1.09M | -998.80K | -1.06M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 358.98M | 356.13M | 353.73M | 353.61M | 353.26M |
| Average Diluted Shares Outstanding | 358.98M | 356.13M | 353.73M | 353.61M | 353.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |